>>> Broadfin Capital (Kevin Kotler - pharma focus) discloses updated portfolio

Broadfin Capital (Kevin Kotler - pharma focus) discloses updated portfolio positions in 13F filing: New ADMA MDCO AGRX positions Highlights from 2017 Q4 filing as compared to 2017 Q3 filing: New positions in: ADMA (~1.1 mln shares), MDCO (~0.37 mln), AGRX (~0.36 mln), ATEC (~0.15 mln), GWPH (~0.12 mln), NSTG (~0.1 mln), VCEL (~0.09 mln) Increased positions in: ATRS (to ~4.54 mln shares from ~3.21 mln shares), TLGT (to ~1.93 mln from ~1.43 mln), ZGNX (to ~0.46 mln from ~0.14 mln), SBBP (to ~3.19 mln from ~2.89 mln), IART (to ~0.33 mln from ~0.08 mln) SSKN (to ~0.2 mln from ~0.05 mln), Maintained positions in: CPRX (~7.1 mln shares), HZNP (~3.02 mln shares), MRTX (~2.45 mln shares), IOVA (~2.34 mln shares), ANGO (~1.73 mln shares), RTRX (~1.64 mln shares), LJPC (~1.03 mln shares) Closed positions in: FOLD (from ~0.14 mln shares), OMI (from ~0.13 mln), ALNY (from ~0.07 mln) Decreased positions in: RGLS (to ~1.51 mln shares from ~4.29 mln shares), CFRX (to ~1.23 mln from ~2.71 mln), HRTX (to ~2.03 mln from ~3.46 mln), CORI (to ~3.43 mln from ~4.44 mln), AVDL (to ~2.59 mln from ~3.57 mln), PETX (to ~4.29 mln from ~5.18 mln), REPH (to ~2.44 mln from ~3.1 mln), ENDP (to ~2.44 mln from ~3.01 mln), AMRN (to ~1.15 mln from ~1.63 mln)

Broadfin Capital (Kevin Kotler - pharma focus) discloses updated portfolio positions in 13F filing: New ADMA MDCO AGRX positions

Highlights from 2017 Q4 filing as compared to 2017 Q3 filing:

New positions in: ADMA (~1.1 mln shares), MDCO (~0.37 mln), AGRX (~0.36 mln), ATEC (~0.15 mln), GWPH (~0.12 mln), NSTG (~0.1 mln), VCEL (~0.09 mln)
Increased positions in: ATRS (to ~4.54 mln shares from ~3.21 mln shares), TLGT (to ~1.93 mln from ~1.43 mln), ZGNX (to ~0.46 mln from ~0.14 mln), SBBP (to ~3.19 mln from ~2.89 mln), IART (to ~0.33 mln from ~0.08 mln) SSKN (to ~0.2 mln from ~0.05 mln),
Maintained positions in: CPRX (~7.1 mln shares), HZNP (~3.02 mln shares), MRTX (~2.45 mln shares), IOVA (~2.34 mln shares), ANGO (~1.73 mln shares), RTRX (~1.64 mln shares), LJPC (~1.03 mln shares)
Closed positions in: FOLD (from ~0.14 mln shares), OMI (from ~0.13 mln), ALNY (from ~0.07 mln)
Decreased positions in: RGLS (to ~1.51 mln shares from ~4.29 mln shares), CFRX (to ~1.23 mln from ~2.71 mln), HRTX (to ~2.03 mln from ~3.46 mln), CORI (to ~3.43 mln from ~4.44 mln), AVDL (to ~2.59 mln from ~3.57 mln), PETX (to ~4.29 mln from ~5.18 mln), REPH (to ~2.44 mln from ~3.1 mln), ENDP (to ~2.44 mln from ~3.01 mln), AMRN (to ~1.15 mln from ~1.63 mln)